• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

  • Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • Countering AMR
  • COVID-19 Research
  • Digital Therapies
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

On the evening of June 16, 2022, an exceptionally bright and warm day, OHE hosted a party to celebrate the 60th anniversary of its existence. The event took place at 4 Hamilton Place, an Edwardian Mansion in the heart of Mayfair,…

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for PolicymakersRead more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes
  • PhRMA

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
When Generic Measures Fail to Reflect What Matters to Patients: Three Case StudiesRead more
© NCI/Unsplash
  • Health Technology Assessment…
  • Measuring and Valuing Outcomes
  • Canada

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Cancer_WellcomeCollection_landscape
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic TherapiesRead more
© WellcomeCollection
Close
OHE
  • All Publications

    Filter by:
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • Countering AMR
    • COVID-19 Research
    • Digital Therapies
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 21st June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

On the evening of June 16, 2022, an exceptionally bright and warm day, OHE hosted a party to celebrate the 60th anniversary of its existence. The event took place at 4 Hamilton Place, an Edwardian Mansion in the heart of Mayfair,…

Share:
MicrosoftTeams-image-6_0

On the evening of June 16, 2022, an exceptionally bright and warm day, OHE hosted a party to celebrate the 60th anniversary of its existence. The event took place at 4 Hamilton Place, an Edwardian Mansion in the heart of Mayfair, London. About 140 attendants were served nibbles and drinks on the terrace with views over Hyde Park and listened to the commemorative speeches of Richard Murray, Chief Executive of The King’s Fund; Graham Cookson, OHE’s Chief Executive Officer; and Adrian Towse, former Director of OHE and now Emeritus Director.

In his address, Graham Cookson put into historical perspective the foundation of the Office of Health Economics in 1962. Since then, the contribution of OHE to the growing body of knowledge in health economics has been substantial and broad, ranging from measuring the cost of diseases and the National Health System to studying whether a medicine is good value, how to incentivise healthcare providers, how to measure patients’ quality of life, healthcare system efficiency, and how to design innovative drug reimbursement systems, among others.

Graham thanked the ABPI for its forward-thinking vision in founding OHE in 1962, but also to the members of the OHE’s different Policy and Research committees over time, the Editorial Board, Visiting Research Fellows and collaborating institutions that have ensured the independence and rigour of OHE’s research. Graham expressed his special gratitude to Adrian Towse for being a visionary director of OHE for 25 years, culminating in establishing OHE as a Charity. George Teeling-Smith, a predecessor of Adrian, was also remembered and thanked, along with OHE’s “smart, hard-working, ambitious, enthusiastic, opinionated and caring” team.

Richard Murray reminisced about the role of health economics and OHE during his long career. Richard mentioned the creation of OHE’s Compendium of Health Statistics at the end of the 1960s as an invaluable asset for economists studying the health system and, therefore, for the decision-makers relying on them. Among other subjects he mentioned, there was the contribution of OHE to the debate on health system efficiency and providing evidence-based arguments in often heated conversations. Above all, Richard congratulated OHE for 60 years of high-quality research and professionalism.

Adrian Towse was in charge of the celebratory toast. Before raising his glass, he highlighted some core moments in OHE’s first 60 years of existence. For instance, in 1983, OHE organised a three-day workshop on the development of quality of life measures, with the attendance of pivotal health economists (Rosser, Williams, Culyer, Maynard and others) that set up the development of the concept of Quality-Adjusted Life Years. Measuring patient outcomes was taken further by the former OHE Director of Research, Nancy Devlin, who became a key member of EuroQol. Adrian highlighted the start of OHE’s long string of Annual Lectures in 1980 with Douglas Black on Health Inequalities, which were followed by many eminent speakers ranging from David Sackett to Kenneth Arrow and Angus Deaton. Adrian took pride in OHE’s aim to always be ahead of the curve with initiatives like leading the way in risk-sharing and coverage and identifying additional elements of value. Adrian also referred to the sadly not-so-successful (yet) campaign for the routine collection of the Patient-Reported Outcome Measure set in the NHS. Adrian thanked John Sussex, former Deputy Director of OHE, for his significant impact on putting OHE where it is today. Finally, Adrian raised his glass to congratulate OHE for its first 60 years of existence, expressed his wishes for many more years to come, and declared his happiness with the direction in which Graham Cookson, along with Lotte Steuten and Mireia Jofre-Bonet, have taken OHE since he passed on its steering.

  • 60th Anniversary

Related News

Prize-hub-banner_1
  • News
  • May 2022

OHE Innovation Policy Prize

Read more
  • News
  • January 2020

OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?

Read more
  • News
  • September 2019

OHE Lunchtime Seminar: Closing the ‘Know-do’ Gap for Health Systems Reform at the Policy Level

Read more
  • News
  • August 2019

OHE Lunchtime Seminar: How Do We Measure the ‘Value’ in Value-based Care?

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 OHE

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!